Anti-TNF strategies in stenosing and fistulizing Crohn?s disease-Reference-Cited by-同舟云学术

Anti-TNF strategies in stenosing and fistulizing Crohn?s disease

Published:2004-09-30 Issue:1 Volume:20 Page:1-8
ISSN:0179-1958
Container-title:International Journal of Colorectal Disease
language:en
Short-container-title:Int J Colorectal Dis

Author:

Holtmann Martin H.,Neurath Markus F.

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/content/pdf/10.1007/s00384-004-0634-0.pdf

Reference65 articles.

1. Shivananda S et al (1996) Incidence of inflammatory bowel disease across Europe. Is there a difference between North and South. Gut 39:690?697

2. Farmer RG, Hawk WA, Turnbull RBJ (1975) National cooperative Crohn?s disease study: extraintestinal manifestations and perianal complications. Gastroenterology 77:914?920

3. Steinberg DM, Cooke WT, Alexander-Williams J (1973) Abscess and fistulae in Crohn?s disease. Gut 14:865?869

4. Holtmann M et al (2002) Das mukosale Immunsystem. Wie klar ist die Pathogenese. Internist 43:1343?1353

5. Hugot JP et al (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn?s disease. Nature 411:599?603

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Oral administration of inflammatory microenvironment-responsive carrier-free infliximab nanocomplex for the targeted treatment of inflammatory bowel disease;Chemical Engineering Journal;2022-10

3. Choosing the right biologic for complications of inflammatory bowel disease;Expert Review of Gastroenterology & Hepatology;2022-02-06

4. The Possible Pathogenic Role of IgG4-Producing Plasmablasts in Stricturing Crohn’s Disease;Pathobiology;2022

5. An Overview of Nano Delivery Systems for Targeting RNA Interference-based Therapy in Ulcerative Colitis;Current Pharmaceutical Design;2021-09-15